Molecular Biologists are at the cutting edge of scientific discovery, exploring the molecular mechanisms that drive cellular functions and influence health and disease. Their work involves analyzing DNA, RNA, and protein interactions to understand how genes are regulated and expressed. By using techniques such as PCR, gene sequencing, and CRISPR gene editing, molecular biologists uncover the underlying causes of genetic disorders, infectious diseases, and cancer. Their research provides critical insights that support the development of targeted therapies, diagnostics, and biotechnology innovations that shape the future of medicine and agriculture.
In the realm of public health and biomedical research, molecular biologists contribute significantly to identifying and characterizing pathogens, tracking viral mutations, and developing molecular diagnostics. Their collaboration with other scientific disciplines helps accelerate breakthroughs in vaccine development, drug design, and gene therapy. As molecular tools become more precise and accessible, these specialists are also playing a growing role in personalized medicine—tailoring treatments based on an individual’s genetic profile. They work across academic institutions, research labs, biotech companies, and clinical settings, translating molecular-level knowledge into real-world solutions. Their ongoing contributions continue to expand our understanding of life at its most fundamental level, driving innovation in both science and healthcare. In an era of rapid scientific advancement, their expertise remains a cornerstone of progress in biomedical research.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States